Fig. 4.

Cumulative incidence curves of hepatic decompensation compared across categories of (A) LiverRisk score (<10, 10 to <15, and ≥15), (B) LSM (<10, 10–15, and >15 kPa), (C) FIB-4 (<1.3, 1.3–2.67, and >2.67), and (D) APRI (<0.5, 0.5–1.5, and >1.5) in cohort I.

SHRs are given compared with the first group (Fine–Gray subdistribution hazard model). APRI, aspartate aminotransferase-to-platelet ratio index; CI, confidence interval; FIB-4, fibrosis-4; LSM, liver stiffness measurement; SHR, subdistribution hazard ratio.